Pharscin Pharma: Injectable Sulbactam-Nafcillin has received drug re-registration approval

Pharscin Pharma announced that it recently received the "Drug Re-registration Approval Notice" for its product, injectable sulbactam-natamycin, issued by the Chongqing Municipal Drug Administration. The drug approval number is valid until October 22, 2030. The re-registration of this product is approved. Since this product has not been produced for a long time, before resuming production, the holder must complete the relevant work according to the requirements of related documents and submit a resumption application to the municipal drug administration. After on-site inspection and passing the quality check of a batch of products, and subsequent two batches of products passing inspection, it can be marketed and sold